• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Alpha Tau Medical Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

    8/29/23 8:20:07 AM ET
    $AGIL
    $BEDU
    $BTCM
    $CACO
    Professional Services
    Consumer Discretionary
    Other Consumer Services
    Real Estate
    Get the next $AGIL alert in real time by email

    Gainers

    • Tivic Health Systems, Inc. (NASDAQ:TIVC) rose 62.4% to $3.15 in pre-market trading after falling 11% on Monday. Tivic Health Systems inked a pact to make its products available on AmerisourceBergen’s third-party marketplace.
    • Shineco, Inc. (NASDAQ:SISI) shares gained 50% to $0.2130 in pre-market trading after declining over 3% on Monday.
    • noco-noco Inc. (NASDAQ:NCNC) shares rose 44.5% to $2.89 in pre-market trading after falling 23% on Monday.
    • Caravelle International Group (NASDAQ:CACO) shares climbed 26.5% to $0.7087 in pre-market trading after falling 11% on Monday.
    • iCoreConnect Inc. (NASDAQ:ICCT) shares gained 23.8% to $1.97 in pre-market trading after dipping 20% on Monday.
    • Bright Scholar Education Holdings Limited (NYSE:BEDU) shares rose 14.7% to $1.01 in pre-market trading. Bright Scholar Education recently announced its unaudited financial results for the six months of fiscal 2023 ended Feb. 28, 2023.
    • Secoo Holding Limited (NASDAQ:SECO) gained 13.8% to $0.5799 in pre-market trading after gaining 6% on Monday.
    • The NFT Gaming Company, Inc. (NASDAQ:NFTG) shares jumped 13.6% to $0.50 in pre-market trading after adding 6% on Monday.
    • NeuBase Therapeutics, Inc. (NASDAQ:NBSE) rose 10.6% to $0.8853 in pre-market trading after falling around 8% on Monday.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) shares surged 8.3% to $3.52 in pre-market trading after the company reported results for the second quarter.

    Losers

    • Orgenesis Inc. (NASDAQ:ORGS) fell 12.1% to $0.4915 in pre-market trading after jumping 36% on Monday.
    • Vahanna Tech Edge Acquisition I Corp. (NASDAQ:VHNA) shares fell 10.6% to $10.42 in pre-market trading after jumping over 20% on Monday.
    • AgileThought, Inc. (NASDAQ:AGIL) fell 8.5% to $0.1709 in pre-market trading after declining 28% on Monday. AgileThought announced a strategic financial restructuring to strengthen financial future.
    • Genius Group Limited (NYSE:GNS) fell 7.4% to $2.13 in pre-market trading after jumping 57% on Monday.
    • BIT Mining Limited (NYSE:BTCM) shares fell 7.2% to $3.08 in pre-market trading after gaining 12% on Monday.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) fell 7.1% to $0.5196 in pre-market trading after gaining 5% on Monday.
    • NeuroPace, Inc. (NASDAQ:NPCE) fell 6.7% to $6.50 in pre-market after gaining 16% on Monday.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) fell 6.1% to $0.3145 in pre-market trading after declining 9% on Monday.
    • YS Biopharma Co., Ltd. (NASDAQ:YS) shares fell 5.7% to $1.15 in pre-market trading. YS Biopharma recently announced the purchase of shares by company officers.
    • HEICO Corporation (NYSE:HEI) fell 5.3% to $159.01 in pre-market trading after reporting third-quarter results.

    Now Read This: Best Buy, HP And 3 Stocks To Watch Heading Into Tuesday

    Get the next $AGIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGIL
    $BEDU
    $BTCM
    $CACO

    CompanyDatePrice TargetRatingAnalyst
    Alpha Tau Medical Ltd.
    $DRTS
    3/4/2026$5.00Overweight → Neutral
    Piper Sandler
    Heico Corporation
    $HEI
    2/27/2026Neutral → Outperform
    BNP Paribas Exane
    Heico Corporation
    $HEI
    1/23/2026$385.00Neutral
    Susquehanna
    Heico Corporation
    $HEI
    12/12/2025$367.00Buy
    Citigroup
    Heico Corporation
    $HEI
    11/18/2025$330.00Neutral
    BNP Paribas Exane
    Heico Corporation
    $HEI
    8/22/2025$315.00 → $335.00Outperform
    RBC Capital Mkts
    Heico Corporation
    $HEI
    6/24/2025$352.00Buy
    Stifel
    Neuropace Inc.
    $NPCE
    5/28/2025$18.00Buy
    H.C. Wainwright
    More analyst ratings

    $AGIL
    $BEDU
    $BTCM
    $CACO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Geiger Uri

    4 - NeuroPace Inc (0001528287) (Issuer)

    3/24/26 4:47:17 PM ET
    $NPCE
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Lacob Joseph

    4 - NeuroPace Inc (0001528287) (Issuer)

    3/24/26 4:45:44 PM ET
    $NPCE
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Kumar Rakhi

    4 - NeuroPace Inc (0001528287) (Issuer)

    3/23/26 4:42:40 PM ET
    $NPCE
    Medical/Dental Instruments
    Health Care

    $AGIL
    $BEDU
    $BTCM
    $CACO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Genius Group CEO Roger Hamilton Buys 300,000 Company Shares on the Open Market

    SINGAPORE, March 17, 2026 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading AI-powered, Bitcoin-first education group, today announced that it has received notice that its CEO and Founder, Roger Hamilton, has made a further purchase of the Company's shares at market price. Mr. Hamilton notified the Company he purchased 300,000 of the Company's shares on March 13, 2025 on the open market, at an average price of $0.37 per share. Mr. Hamilton has purchased a total of 5.5 million shares of the company for a total of US$2.9 million over a series of seven separate transactions since January 2024. Mr. Hamilton said "Insider purchases of the company

    3/17/26 8:00:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Alpha Tau to Present at Sidoti March Virtual Small Cap Conference

    JERUSALEM, March 16, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ:DRTS, DRTSW)) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT® today announced that CFO Raphi Levy will present at the Sidoti Virtual Small Cap Conference taking place on March 18-19, 2026. Event:Sidoti Virtual Small Cap ConferenceFormat:Company PresentationDate:March 18, 2026Time:10:00 – 10:30AM ETLocation:Virtual Mr. Levy will be available for 1x1 investor meetings at the conference. Please reach out to your Sidoti representative to schedule. About Alpha Tau Medical Ltd.  Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, de

    3/16/26 10:02:00 AM ET
    $DRTS
    Medical/Dental Instruments
    Health Care

    Diamond Equity Research Releases Update Note on Genius Group Ltd. (NYSE: GNS)

    New York, March 11, 2026 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an update note on Genius Group Ltd. (NYSE:GNS). The update note includes information on the Genius Group Ltd.' financial results, management commentary, recent developments, outlook, and risks. The research summary below is from a report commissioned by Genius Group Ltd. and produced by Diamond Equity Research. Investors can find various risk factors in the update report and in the respective financial filings for Genius Group Limited.  The full research report is available below. Genius Group March 2026 Update Note  Highlights

    3/11/26 8:00:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AGIL
    $BEDU
    $BTCM
    $CACO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Schonfeld Strategic Advisors Llc sold $79,589 worth of shares (41,400 units at $1.92) and bought $372,143 worth of shares (146,800 units at $2.54) (SEC Form 4)

    4 - iCoreConnect Inc. (0001906133) (Issuer)

    4/28/25 6:12:27 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Director Pasqual John was granted 137,255 shares and bought $2,900 worth of shares (5,000 units at $0.58), increasing direct ownership by 250% to 199,159 units (SEC Form 4)

    4 - iCoreConnect Inc. (0001906133) (Issuer)

    12/9/24 5:00:42 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Mcdermott Robert P was granted 152,893 shares and bought $49,421 worth of shares (276,785 units at $0.18), increasing direct ownership by 51% to 1,269,885 units (SEC Form 4)

    4 - iCoreConnect Inc. (0001906133) (Issuer)

    12/6/24 5:00:15 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    $AGIL
    $BEDU
    $BTCM
    $CACO
    SEC Filings

    View All

    Tivic Health Systems Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Tivic Health Systems, Inc. (0001787740) (Filer)

    3/20/26 5:15:08 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Tivic Health Systems Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Tivic Health Systems, Inc. (0001787740) (Filer)

    3/13/26 5:27:44 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Orgenesis Inc. filed SEC Form 8-K: Leadership Update

    8-K - Orgenesis Inc. (0001460602) (Filer)

    3/13/26 3:48:44 PM ET
    $ORGS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $BEDU
    $BTCM
    $CACO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alpha Tau downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Alpha Tau from Overweight to Neutral and set a new price target of $5.00

    3/4/26 8:30:52 AM ET
    $DRTS
    Medical/Dental Instruments
    Health Care

    HEICO upgraded by BNP Paribas Exane

    BNP Paribas Exane upgraded HEICO from Neutral to Outperform

    2/27/26 8:21:04 AM ET
    $HEI
    Aerospace
    Industrials

    Susquehanna initiated coverage on HEICO with a new price target

    Susquehanna initiated coverage of HEICO with a rating of Neutral and set a new price target of $385.00

    1/23/26 8:19:26 AM ET
    $HEI
    Aerospace
    Industrials

    $AGIL
    $BEDU
    $BTCM
    $CACO
    Leadership Updates

    Live Leadership Updates

    View All

    Genius Group Engages DLA Piper as Advisor on Australian Securities Exchange (ASX) Dual Listing.

    SINGAPORE, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading AI-powered, Bitcoin-first education group, today announced that it has appointed DLA Piper as advisor on the Company's application for a dual listing on Australian Securities Exchange (ASX). Following the Company's Board of Directors approval on August 8, 2025 to pursue a dual listing on an Asia Pacific exchange to enhance shareholder value and accessibility, the Company has been investigating potential stock exchanges, resulting in a shortlist of three exchanges in Australia (ASX), South Korea (KRX) and Hong Kong (HKEX). From the shortlist, the Company has selected t

    12/18/25 8:00:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Genius Group Announces New Analyst Report from Diamond Equity Research

    SINGAPORE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group", "GNS" or the "Company"), a leading AI-powered, Bitcoin-first education group, today announced the release of a new Analyst Update Report from Diamond Equity Research, an issuer sponsored equity research firm focused on small capitalization companies, covering Genius Group's common stock. Genius Group has worked with Diamond Equity Research to perform independent research that will create greater awareness and exposure in the investment community for the company's AI-powered education growth plans and Bitcoin Treasury strategy. Report Highlights Notable highlights from the report include: Broad

    11/24/25 8:30:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Diamond Equity Research Releases Update Note on Genius Group Ltd. (NYSE: GNS)

    New York, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an update note on Genius Group Ltd. (NYSE:GNS). The update note includes information on the Genius Group Ltd.' financial results, management commentary, recent developments, outlook, risks, and our revised valuation estimates. The research summary below is from a report commissioned by Genius Group Ltd. and produced by Diamond Equity Research. Investors can find various risk factors in the update report and in the respective financial filings for Genius Group Limited.  The full research report is available below. Genius Group Nove

    11/21/25 8:00:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AGIL
    $BEDU
    $BTCM
    $CACO
    Financials

    Live finance-specific insights

    View All

    NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook

    -- Reported quarterly revenue of $26.6 million in Q4 2025 representing 24% growth -- -- Reiterates previously issued 2026 guidance assuming 20% to 22% growth in core RNS® revenue from existing indications, excluding any contribution from idiopathic generalized epilepsy (IGE) -- -- Continues to expect IGE contribution following potential NAUTILUS PMA-Supplement (PMA-S) approval in mid-2026 -- NeuroPace, Inc. (NASDAQ:NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a corporate update. Fourth Quarter 2025 Financial Highlights To

    3/3/26 4:05:00 PM ET
    $NPCE
    Medical/Dental Instruments
    Health Care

    NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026

    NeuroPace, Inc. (NASDAQ:NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter of 2025 after market close on Tuesday, March 3, 2026. The company's management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). Investors interested in listening to the conference call may do so by accessing a live webcast of the event here. Individuals interested in participating in the call via telephone may access the call by dialing + 1 (800) 715-9871 and referencing Conference ID 8467256. The webcast will be archived on the company's in

    2/20/26 4:30:00 PM ET
    $NPCE
    Medical/Dental Instruments
    Health Care

    Diamond Equity Research Releases Update Note on Genius Group Ltd. (NYSE: GNS)

    New York, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an update note on Genius Group Ltd. (NYSE:GNS). The update note includes information on the Genius Group Ltd.' financial results, management commentary, recent developments, outlook, and risks. The research summary below is from a report commissioned by Genius Group Ltd. and produced by Diamond Equity Research. Investors can find various risk factors in the update report and in the respective financial filings for Genius Group Limited.  The full research report is available below. Genius Group February 2026 Update Note  Highlight

    2/17/26 8:00:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AGIL
    $BEDU
    $BTCM
    $CACO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/12/24 9:44:00 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/5/24 4:08:58 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Orgenesis Inc.

    SC 13G/A - Orgenesis Inc. (0001460602) (Subject)

    12/4/24 6:51:18 PM ET
    $ORGS
    Biotechnology: Pharmaceutical Preparations
    Health Care